Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2. This appears to be a minor site update with no changes to study details or functionality.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision updated to v3.4.1; previous revision v3.4.0 was removed.SummaryDifference0.0%

- Check30 days agoChange DetectedAdded a glossary toggle (Show glossary) and introduced labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Updated the page revision to v3.4.0, and removed the former wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study status updated to Active, not recruiting (revision v3.3.4). A large portion of investigator contact information and names was removed from the page.SummaryDifference9%

- Check66 days agoChange DetectedAdded a new 'Locations' section listing recruitment sites across Colorado, District of Columbia, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Texas, Virginia, and Washington; revision updated to v3.3.3.SummaryDifference0.8%

- Check95 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. This appears to be a minor metadata update with no changes to study content or displayed details.SummaryDifference0.0%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.